Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.Individuals who die of immune ...

A bold new vision for the Champions League was launched this season, meaning more games and more money for European soccer’s ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Kidwai is the first government hospital to implement robotic technology, having integrated the advanced Da Vinci robotic ...

Surgeons at Millard Fillmore Suburban have been using this option for more than a decade and are continuously developing ways to collaborate for the benefit of patients.

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

David M. Waterhouse, MD, MPH, and Molly Mendenhall, MBOE, LSSBB, BSN, RN, discuss how the implementation of Lean Six Sigma methodology at Oncology Hematology Care in Cincinnati, Ohio, has transformed ...

On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...

Afinitor plus Somatuline showed an improved survival compared with Afinitor monotherapy in patients with gastroenteropancreatic neuroendocrine tumors.

Cancer patients with high muscle strength and cardiorespiratory fitness (CRF) had a significantly lower risk of death from any cause, including those with advanced cancers, a large retrospective ...

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

Some six and a half years since its debut, Servier’s U.S. arm has made good on its oncology growth ambitions while managing to stay true to its patient-centric ethos along the way. | Some six and a ...